Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoea

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 2, 2009, Pages 343-347

  Mendez Arancibia, Eva ^a   Pitart, Cristina ^a   Ruiz, Joaquim ^b   Marco, Francesc ^a   Gascón, Joaquim ^b   Vila, Jordi ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

EAEC; ETEC; India; Quinolones; Resistance

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; NALIDIXIC ACID; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; DEVELOPING COUNTRY; DNA SEQUENCE; ENTEROAGGREGATIVE ESCHERICHIA COLI; ENTEROTOXIGENIC ESCHERICHIA COLI; GENE MUTATION; HUMAN; INDIA; INFECTIOUS DIARRHEA; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EVOLUTION; NONHUMAN; NORTH AMERICA; TRAVELLER DIARRHEA;

AFRICA; AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; DIARRHEA; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TRAVEL;

EID: 67650770116     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp178     Document Type: Article

References (20)

1. Nataro JP, Kaper JB. Diarrhoeagenic Escherichia coli. Clin Microbiol Rev 1998; 11: 142-85.
2. Adachi JA, Ostrosky-Zeichner L, DuPont HL et al. Empirical anti-microbial therapy for traveller's diarrhoea. Clin Infect Dis 2000; 31: 2079-83.
3. Vila J, Vargas M, Ruiz J et al. Quinolone resistance in enterotoxigenic Escherichia coli causing diarrhoea in travelers to India in comparison with other geographical areas. Antimicrob Agents Chemother 2000; 44: 1731-3.
4. Vila J, Vargas M, Ruiz J et al. Susceptibility patterns of entero-aggregative Escherichia coli associated with traveller's diarrhoea: Emergence of quinolone resistance. J Med Microbiol 2001; 50: 996-1000.
5. Vila J. Fluooroquinolones. In: White DG, Alekshun MN, McDermott PF eds. Frontiers in Antimicrobial Resistance: A Tribute to Stuart B. Levy Washington, DC: ASM Press, 2005; 41-52.
6. Vargas M, Gascón J, Gallardo F et al. Prevalence of diarrhoeagenic Escherichia coli strains by PCR in patients with traveller's diarrhoea. Clin Microbiol Infect 1998; 4: 682-8.
7. Ruiz J, Vargas M, Nataro JP et al. Validación de la técnica de PCR para la detección de Escherichia coli enteroagregativa causante de diarrea del viajero. Enfer Infec Microbiol Clin 2005; 23: 479-81.
8. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement M100-S17. CLSI, Wayne, PA, USA, 2008.
9. Vila J, Ruiz J, Marco F et al. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob Agents Chemother 1994; 38: 2477-9.
10. Vila J, Ruiz J, Goñi P et al. Detection of mutations in the parC gene of quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother 1996; 40: 491-3.
11. Robicsek A, Strahilevitz J, Sahm DF et al. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 2006; 50: 2872-4.
12. Sanchez-Cespedes J, Balsco MD, Marti S et al. Plasmid-mediated QnrS2 determinant from a clinical Aeromonas veronii isolate. Antimicrob Agents Chemother 2008; 52: 2990-1.
13. Ruiz J, Marco F, Oliveira I et al. Trends in antimicrobial resistance in Campylobacter spp. causing traveller's diarrhoea. APMIS 2007; 115: 218-24.
14. Cabrera R, Ruiz J, Marco F et al. Mechanisms of resistance to several antimicrobial agents in Salmonella clinical isolates causing traveller's diarrhoea. Antimicrob Agents Chemother 2004; 48: 3934-9.
15. Mensa L, Marco F, Vila J et al. Quinolone resistance among Shigella spp. isolated from travellers returning from India. Clin Microbiol Infect 2008; 14: 279-81.
16. DuPont HL. Therapy for and prevention of traveller's diarrhoea. Clin Infect Dis 2007; 45 Suppl 1: S78-84.
17. Ansdell VE, Ericsson CD. Prevention and empiric treatment of traveller's diarrhoea. Med Clin North Am 1999; 83: 945-73.
18. Petrucelli BP, Murphy GS, Sanchez JL et al. Treatment of traveller's diarrhoea with ciprofloxacin and loperamide. J Infect Dis 1992; 165: 557-60.
19. Wistrom J, Jertborn M, Ekwall E et al. Empiric treatment of acute diarrhoeal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group. Ann Intern Med 1992; 117: 202-8.
20. Ericsson CD, DuPont HL, Mathewson JJ. Optimal dosing of ofloxacin with loperamide in the treatment of non-dysenteric traveller's diarrhoea. J Travel Med 2001; 8: 207-9.